文献速递贫血与红细胞疾病

RNAi介导的肝脏Tmprss6降低可减轻中间型β地中海贫血脾切除小鼠模型的贫血和继发性铁过载

RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermedia.
PubMed 文献 · Am J Hematol · 2018-03-23

在脾切除的中间型β地中海贫血Hbbth3/+小鼠中,使用GalNAc偶联的靶向Tmprss6的siRNA(GalNAc-Tmprss6)治疗可显著降低Tmprss6表达并适当升高hepcidin表达,明显改善贫血、减少无效造血及血清和组织铁负荷,提示该策略对脾切除的β地中海贫血患者可能有效。

要点

  • 脾切除Hbbth3/+小鼠接受GalNAc-Tmprss6后Tmprss6表达显著降低,hepcidin表达适当升高。
  • 治疗组贫血明显改善,与无效造血减轻相关。
  • 治疗组血清和组织铁负荷均降低,与未脾切除动物相似。

核心结论

  • 结果表明,RNAi介导的Tmprss6降低即使在脾切除的β地中海贫血患者中也可能产生积极效果。

研究设计与样本

  • 研究使用脾切除的β地中海贫血Hbbth3/+小鼠,给予靶向Tmprss6的GalNAc偶联siRNA(GalNAc-Tmprss6)治疗,并监测血液学和铁参数。

主要发现

  • GalNAc-Tmprss6治疗显著降低脾切除Hbbth3/+动物的Tmprss6表达,并适当升高hepcidin表达。
  • 与未脾切除动物相似,治疗动物因无效造血减轻而贫血明显改善,血清和组织铁负荷均降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diminished β-globin synthesis in β-thalassemia is associated with ineffective erythropoiesis, leading to secondary iron overload caused by inappropriately low levels of hepcidin and to splenomegaly in the symptomatic thalassemias. Splenectomy is often employed in patients with β-thalassemia to reduce hemolysis. Expression of the iron regulatory peptide hormone hepcidin is repressed by the serine protease TMPRSS6. Hepcidin induction by RNAi-mediated inhibition of TMPRSS6 expression reduces iron overload and mitigates anemia in murine models of β-thalassemia intermedia. To interrogate the efficacy of RNAi-mediated reduction of Tmprss6 in splenectomized β-thalassemia, splenectomized β-thalassemic Hbbth3/+ animals were treated with a GalNAc-conjugated siRNA targeting Tmprss6 (GalNAc-Tmprss6) and their hematological and iron parameters monitored. We demonstrate that treatment with GalNAc-Tmprss6 significantly diminishes Tmprss6 expression and appropriately elevates hepcidin expression in splenectomized Hbbth3/+ animals. Similar to unsplenectomized animals, treated animals have markedly improved anemia due to diminished ineffective erythropoiesis and reduced iron loading in both serum and tissue. These results suggest that RNAi-mediated reduction of Tmprss6 may have positive outcomes even in splenectomized β-thalassemia patients.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Schmidt PJ, Liu K, Visner G, et al. RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermedia. Am J Hematol. 2018. PMID: 29498084. doi:10.1002/ajh.25079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。